Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • PKC
    (6)
  • Apoptosis
    (5)
  • Antibacterial
    (3)
  • Antibiotic
    (2)
  • PKA
    (2)
  • Antifungal
    (1)
  • Autophagy
    (1)
  • Bcl-2 Family
    (1)
  • CaMK
    (1)
  • Others
    (6)
Filter
Search Result
Results for "

staurosporine

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    15
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Dye Reagents
    1
    TargetMol | Dye_Reagents
  • Natural Products
    8
    TargetMol | Natural_Products
Staurosporine
CGP 41251, Antibiotic AM-2282, AM-2282
T668062996-74-1
Staurosporine (AM-2282) is a protein kinase inhibitor with ATP-competitive and non-selective inhibitory activity (IC50=6/15/2/3/3000 nM) against PKC, PKA, c-Fgr, phosphorylase kinase and TAOK2. Staurosporine also induces apoptosis.
  • $56
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Staurosporine-Boc
TN7835120685-17-8
Staurosporine-Boc is a natural product isolated from the actinomycete Streptomyces staurosporeus and functions as a potent, non-selective protein kinase inhibitor. It can inhibit various protein kinases, including protein kinase C (PKC), tyrosine kinase, and serine/threonine kinase. Due to its broad inhibitory profile, Staurosporine-Boc is widely used as a tool compound in biological research, particularly in the study of cell signaling pathways.
  • Inquiry Price
Backorder
Size
QTY
K-252a
SF2370, Antibiotic SF 2370, Antibiotic K 252a
T1563699533-80-9
K-252a is a protein kinase inhibitor targeting serine-threonine, tyrosine, and CAM kinases. In vitro, it blocks NGF-induced TrkA signalling and neural differentiation, exhibiting antitumour, antibacterial, anti-inflammatory, and neuroprotective activities.
  • $99
In Stock
Size
QTY
TargetMol | Citations Cited
K-252c
T1563885753-43-1
K-252c is a staurosporine analog isolated from Nocardiopsis sp. and is a cell-permeable PKC inhibitor (IC50: 2.45 μM). K-252c also inhibits β-lactamase, chymotrypsin, and malate dehydrogenase. K-252c causes apoptosis in human chronic myelogenous leukemia cancer cells.
  • $853
35 days
Size
QTY
Picroside I
6'-Cinnamoylcatalpol
T278727409-30-9
Picroside I (6'-Cinnamoylcatalpol), a hepatoprotective agent, is reported to be antimicrobial and used against hepatitis B. It has antioxidant, and anti-inflammatory activities, it may be the valuable anti-invasive drug candidates for cancer therapy by suppressing Collagenases and Gelatinases. Picroside I can enhance basic fibroblast growth factor(bFGF)-, staurosporine- or dbc-mitogen-activated protein (MAP)-induced neurite outgrowth from PC12D cells.
  • $50
In Stock
Size
QTY
Nardosinone
T6S174023720-80-1
1. Nardosinone has inhibitory effect on Ang II-induced hypertrophy in H9c2 cells, might be mediated by targeting PI3K/Akt and MEK/ERK signaling pathways. 2. Nardosinone could protect against the neuronal injury exposed to OGD, which may be relevant to the
  • $30
In Stock
Size
QTY
Tanshinone IIB
TN225717397-93-2
Co-treatment with Tanshinone IIB (TSB) significantly inhibits the DNA laddering, cytotoxicity and apoptosis of rat cortical neurons induced by staurosporine in a concentration-dependent manner; TSB also suppresses the elevated Bax protein and decreased bc
  • $971
Inquiry
Size
QTY
MAP3K5-IN-1
TN76022226941-29-1
Compound 7, also known as 3′-O-Demethyl-4′-N-demethyl-4′-N-acetyl-4′-epi-staurosporine, serves as an inhibitor of protein kinases, displaying IC50 values of 0.092 μM for PKC-α, 0.26 μM for ROCK, and 0.77 μM for ASK1. Additionally, this compound exhibits significant cytotoxicity towards PC-3 cancer cells, with an IC50 of 0.16 μM [1].
  • Inquiry Price
Inquiry
Size
QTY